AU2003285841A1 - A process for the preparation of crystalline form 1 or clopidogrel hydrogen sulfate - Google Patents

A process for the preparation of crystalline form 1 or clopidogrel hydrogen sulfate

Info

Publication number
AU2003285841A1
AU2003285841A1 AU2003285841A AU2003285841A AU2003285841A1 AU 2003285841 A1 AU2003285841 A1 AU 2003285841A1 AU 2003285841 A AU2003285841 A AU 2003285841A AU 2003285841 A AU2003285841 A AU 2003285841A AU 2003285841 A1 AU2003285841 A1 AU 2003285841A1
Authority
AU
Australia
Prior art keywords
preparation
crystalline form
hydrogen sulfate
clopidogrel hydrogen
clopidogrel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003285841A
Other versions
AU2003285841A8 (en
Inventor
Roman Balicki
Marcin Cybulski
Magdalena Glice
Katarzyna Korczak
Grzegorz Maciejewski
Wioleta Maruszak
Janina Piechaczek
Jadwiga Serafin
Wieslaw Szelejewski
Maria Wysoczynska
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ANPHARM PRZEDSIEBIORSTWO FARMACEUTYCZNE SA
Original Assignee
ANPHARM PRZED FARMACEUTYCZNE S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ANPHARM PRZED FARMACEUTYCZNE S filed Critical ANPHARM PRZED FARMACEUTYCZNE S
Publication of AU2003285841A8 publication Critical patent/AU2003285841A8/en
Publication of AU2003285841A1 publication Critical patent/AU2003285841A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003285841A 2002-11-28 2003-11-26 A process for the preparation of crystalline form 1 or clopidogrel hydrogen sulfate Abandoned AU2003285841A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PL25442702 2002-11-28
PLP.254427 2002-11-28
PCT/PL2003/000130 WO2004048385A2 (en) 2002-11-28 2003-11-26 A process for the preparation of crystalline form 1 or clopidogrel hydrogen sulfate

Publications (2)

Publication Number Publication Date
AU2003285841A8 AU2003285841A8 (en) 2004-06-18
AU2003285841A1 true AU2003285841A1 (en) 2004-06-18

Family

ID=32389835

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003285841A Abandoned AU2003285841A1 (en) 2002-11-28 2003-11-26 A process for the preparation of crystalline form 1 or clopidogrel hydrogen sulfate

Country Status (2)

Country Link
AU (1) AU2003285841A1 (en)
WO (1) WO2004048385A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10337773A1 (en) * 2003-08-13 2005-03-24 Krka Tovarna Zdravil, D.D. Crystallization of solid forms of clopidogrel addition salts
HUE029459T2 (en) * 2004-04-19 2017-02-28 Krka Tovarna Zdravil D D Novo Mesto Processes for the preparation of clopidogrel hydrogen sulfate polymorphic form i
RU2008146758A (en) * 2006-04-27 2010-06-10 Инд-Свифт Лэборетриз Лимитед (In) METHOD FOR PRODUCING POLYMORPHIC FORMS OF CLOPIDOGEL HYDROSULPHATE
CA2655844A1 (en) * 2006-08-03 2008-02-14 Teva Pharmaceutical Industries Ltd. Process for preparing clopidogrel bisulphate
EP2114957A4 (en) * 2007-01-29 2011-06-08 Ipca Lab Ltd Process for preparation of crystalline clopidogrel hydrogen sulphate form i
PL382055A1 (en) * 2007-03-23 2008-09-29 Koźluk Tomasz Nobilus Ent Production method of crystalline form of clopidogrel 1 hydrogen sulphate
EP2107061A1 (en) 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically enriched clopidogrel
WO2011042804A2 (en) 2009-10-08 2011-04-14 Jubliant Life Sciences Limited An improved process for the preparation of clopidogrel hydrogen sulfate form i
WO2011051976A2 (en) 2009-10-30 2011-05-05 Matrix Laboratories Ltd An improved process for the preparation of clopidogrel bisulfate form i
CN102875568B (en) * 2012-09-06 2015-12-09 苏州晶云药物科技有限公司 The method of the pure crystal formation I of preparation (+)-(S)-SR-25990C
KR102220480B1 (en) 2019-02-13 2021-02-25 한국바이오켐제약 주식회사 Methods for preparing clopidogrel bisulphate and pharmaceutical composition comprising the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2623810B2 (en) * 1987-02-17 1992-01-24 Sanofi Sa ALPHA SALTS- (TETRAHYDRO-4,5,6,7 THIENO (3,2-C) PYRIDYL-5) (2-CHLORO-PHENYL) -THETHYL ACETATE DEXTROGYRE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2779726B1 (en) * 1998-06-15 2001-05-18 Sanofi Sa POLYMORPHIC FORM OF CLOPIDOGREL HYDROGENOSULFATE
PT1467735E (en) * 2001-12-18 2009-03-10 Teva Pharma Polymorphs of clopidogrel hydrogensulfate

Also Published As

Publication number Publication date
AU2003285841A8 (en) 2004-06-18
WO2004048385A2 (en) 2004-06-10
WO2004048385A3 (en) 2004-08-05

Similar Documents

Publication Publication Date Title
IL169146A0 (en) Process for the production of 2'-branched nucleosides
IL169314A0 (en) Process for the production of 3'-nucleoside prodrugs
AU2001290486A1 (en) A process for the manufacture of surface elements
PL368984A1 (en) Process for the preparation of crystalline imipenem
SG99351A1 (en) Process for the manufacture of a crystalline solid
WO2005016931A3 (en) Crystallisation of solid forms of clopidogrel addition salts
AU2003285841A1 (en) A process for the preparation of crystalline form 1 or clopidogrel hydrogen sulfate
IL160193A0 (en) Process for the preparation of a 14-hydroxynormorphinone derivative
AU2003267565A1 (en) Process for the production of a fuel composition
AU2003298178A1 (en) Process for the preparation of an essentially pure polymorph of an n-pyrazolyl-n'-naphthyl-urea
AU2003232800A1 (en) Co-grinding process for the preparation of a ternary composition
AU2003292452A1 (en) A process for the preparation of a pharmaceutically pure polymorphic form i of olanzapine
EP1478396A4 (en) Process for the preparation of a nutrient formulation
AU2002367890A1 (en) Process for the preparation of 4-methyl-thiazole-5-carbaldehyde intermediate
AU2566100A (en) Process for the production of a nutritional composition
AU2002310898A1 (en) Process for the preparation of a polymer-amine
AU2001234188A1 (en) Processes for the production of thienopyrimidine derivatives
ZA200504954B (en) Process for the production of 2'-branched nucleosides
IL162770A0 (en) Process for the preparation methylsteroids of 7
AU2003223104A1 (en) A process for the preparation of indolymaleimides
PL373892A1 (en) Process for the preparation of amorphous form of torsemide
AU2003276510A1 (en) An improved process for the preparation of biotin
AU2002356430A1 (en) A novel polymorph of clopidogrel hydrogen sulfate
AU2003247159A1 (en) A novel process for the preparation of cilazapril
IL174980A0 (en) Process for the preparation of a trifluoromethylthioether

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase